AIIMS BSc (H) Nursing 2021 entrance exam postponed again due to COVID-19; check aiimsexams.ac.in

-

AIIMS BSc (H) Nursing 2021: The All India Institute of Medical Sciences (AIIMS), New Delhi, has postponed the AIIMS BSc (H) Nursing entrance examination again due to the surge of the coronavirus cases in the country.

As per an official notice from the institute, keeping in mind the COVID-19 break, AIIMS authorities have decided to postpone the entrance exam which was scheduled to take place in June 2021.

The Institute further mentioned that the revised dates for the same exam will be notified soon via the official portal i.e. aiimsexams.ac.in.

The AIIMS BSc Nursing examination was earlier scheduled to be conducted on 27 June. This exam will be conducted to select candidates who are seeking admission to 571 BSc (H) Nursing seats offered at AIIMS campuses that are located in New Delhi, Bhopal, Bhubaneswar, Jodhpur, Patna, Raipur and Rishikesh.

Meanwhile, the admit cards for AIIMS BSc (H) Nursing entrance exam were scheduled to be released on 2 July. However, as the exam has been postponed, the process for admission is likely to get delayed.

Candidates who are registered successfully for the examination can download the AIIMS Nursing 2021 admit card after the Institute notifies.

Earlier, the institute had notified that the examination was to be held in a computer-based mode and the mode of language would be English.

The exam will be held for two hours (120 minutes) where aspirants would be required to answer 100 questions. The questions would be objective in nature and will have multiple choices for answers.

Candidates should also note that the marking system will follow +1 for each correct answer and -1 mark for each incorrect answer.

Appearing candidates are requested to keep a check on the official website of AIIMS for important updates and information related to the exam.



from Firstpost India Latest News https://ift.tt/3vWlpOj
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more